The effects of NSAIDs on types I, II, and III collagen metabolism in a rat osteoarthritis model-Reference-Cited by-同舟云学术

The effects of NSAIDs on types I, II, and III collagen metabolism in a rat osteoarthritis model

Published:2011-06-17 Issue:8 Volume:32 Page:2401-2405
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Ou Yun-Sheng,Tan Chao,An Hong,Jiang Dian-Ming,Quan Zheng-Xue,Tang Ke,Luo Xiao-Ji

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00296-011-1978-8.pdf

Reference22 articles.

1. Creamer P, Hochberg MC (1997) Osteoarthritis. Lancet 350:503–509

2. Lin J, Zhang W, Jones A, Doherty M (2004) Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 329:324–326

3. Henrotin YE, Labasse AH, Simonis PE et al (1999) Effects of nimesulide and sodium diclofenac on interleukin-6, interleukin-8, proteoglycans and prostaglandin E2 production by human articular chondrocytes in vitro. Clin Exp Rheumatol 17:151–160

4. Ding C (2002) Do NSAIDs affect the progression of osteoarthritis? Inflammation 26:139–142

5. Cryer B, Dubois A (1998) The advent of highly selective inhibitors of cyclooxygenaseda review. Prostaglandins Other Lipid Mediat 56:341–361

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Cuminaldehyde and Indomethacin Co-Administration on Inflammatory Responses in MIA-Induced Osteoarthritis in Rats;Pharmaceuticals;2024-05-14

2. Key Musculoskeletal Interventions;Orthopaedic and Trauma Nursing;2022-12-16

3. Nonsteroidal Anti-Inflammatory Drugs: Risks and Benefits;Неврология и нейрохирургия. Восточная Европа;2020-11-17

4. Regulation of gene expression by MF63, a selective inhibitor of microsomal PGE synthase 1 (mPGES1) in human osteoarthritic chondrocytes;British Journal of Pharmacology;2020-08-10

5. Dihydroartemisinin derivative DC32 inhibits inflammatory response in osteoarthritic synovium through regulating Nrf2/NF-κB pathway;International Immunopharmacology;2019-09